|
|
|
Volumn 21, Issue 5, 1995, Pages 360-364
|
|
Effect of Tolrestat on oesophageal transit time and cholecystic motility in Type 2 diabetic patients with asymptomatic diabetic neuropathy
a
|
|
Author keywords
autonomic neuropathy; cholecystic motility; oesophageal transit time; Tolrestat; Type 2 diabetes mellitus
|
|
Indexed keywords
ALDOSE REDUCTASE INHIBITOR;
TOLRESTAT;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETIC NEUROPATHY;
DRUG EFFICACY;
DRUG SAFETY;
ESOPHAGUS MOTILITY;
FEMALE;
GALLBLADDER MOTILITY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RANDOMIZED CONTROLLED TRIAL;
VIBRATION SENSE;
AGED;
ALDEHYDE REDUCTASE;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEUROPATHIES;
ENZYME INHIBITORS;
ESOPHAGUS;
FEMALE;
FOLLOW-UP STUDIES;
GALLBLADDER;
GASTROINTESTINAL TRANSIT;
HUMANS;
MALE;
MIDDLE AGED;
NAPHTHALENES;
STATISTICS;
TIME FACTORS;
|
|
EID: 0029569074
PISSN: 03381684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
